[go: up one dir, main page]

IL188937A0 - Hybrid polypeptides with selectable properties - Google Patents

Hybrid polypeptides with selectable properties

Info

Publication number
IL188937A0
IL188937A0 IL188937A IL18893708A IL188937A0 IL 188937 A0 IL188937 A0 IL 188937A0 IL 188937 A IL188937 A IL 188937A IL 18893708 A IL18893708 A IL 18893708A IL 188937 A0 IL188937 A0 IL 188937A0
Authority
IL
Israel
Prior art keywords
hybrid polypeptides
selectable properties
selectable
properties
polypeptides
Prior art date
Application number
IL188937A
Original Assignee
Amylin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/206,903 external-priority patent/US8076288B2/en
Priority claimed from US11/301,744 external-priority patent/US7723471B2/en
Priority claimed from PCT/US2006/031724 external-priority patent/WO2007022123A2/en
Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc
Publication of IL188937A0 publication Critical patent/IL188937A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL188937A 2005-08-11 2008-01-22 Hybrid polypeptides with selectable properties IL188937A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20166405A 2005-08-11 2005-08-11
US11/206,903 US8076288B2 (en) 2004-02-11 2005-08-17 Hybrid polypeptides having glucose lowering activity
US11/301,744 US7723471B2 (en) 2004-02-11 2005-12-12 Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
PCT/US2006/031724 WO2007022123A2 (en) 2005-08-11 2006-08-11 Hybrid polypeptides with selectable properties

Publications (1)

Publication Number Publication Date
IL188937A0 true IL188937A0 (en) 2008-04-13

Family

ID=39662713

Family Applications (1)

Application Number Title Priority Date Filing Date
IL188937A IL188937A0 (en) 2005-08-11 2008-01-22 Hybrid polypeptides with selectable properties

Country Status (7)

Country Link
JP (1) JP2009504681A (en)
KR (1) KR101399178B1 (en)
CN (1) CN101296942A (en)
EA (1) EA014647B1 (en)
IL (1) IL188937A0 (en)
MX (1) MX2008002028A (en)
ZA (1) ZA200801138B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2403038C2 (en) * 2008-09-18 2010-11-10 Общество с ограниченной ответственностью "Идеи для здоровья. Группа компаний" Method of treating and/or prevention of excessive body weight and/or obesity and/or metabolic disorders
EP2416797A4 (en) * 2009-04-10 2013-04-24 Amylin Pharmaceuticals Llc AMYLINE AGONIST COMPOUNDS FOR MAMMALS WITH STROGEN DEFICIENCY
AU2010321587A1 (en) * 2009-11-23 2012-06-07 Amylin Pharmaceuticals, Inc. Polypeptide Conjugate
GB201001333D0 (en) * 2010-01-27 2010-03-17 Imp Innovations Ltd Novel compounds and their effects on feeding behaviour
AU2011247452B2 (en) * 2010-04-27 2016-03-17 Zealand Pharma A/S Peptide conjugates of GLP-1 receptor agonists and gastrin and their use
RU2552221C2 (en) * 2010-07-15 2015-06-10 Общество С Ограниченной Ответственностью "Научно-Производственная Фирма "Материа Медика Холдинг" Method of treating obesity and accompanying metabolic disorders and medication for treating obesity and accompanying metabolic disorders
US20140221282A1 (en) * 2011-05-25 2014-08-07 Astrazeneca Pharmaceuticals Lp Long duration dual hormone conjugates
TWI617574B (en) * 2012-12-11 2018-03-11 梅迪繆思有限公司 Glucagon and glp-1 co-agonists for the treatment of obesity
JP2017532292A (en) * 2014-08-11 2017-11-02 オルバニー メディカル カレッジ Myristoylated leptin-related peptides and uses thereof
KR101689803B1 (en) * 2015-11-17 2016-12-27 고려대학교 산학협력단 Composition for preventing or treating of diabetes or obesity containing Apelin-16
WO2017120220A1 (en) * 2016-01-04 2017-07-13 Adepthera Llc Peptide analogs
JP6889432B2 (en) * 2016-04-28 2021-06-18 学校法人甲南学園 Resin-fixed peptide
BR112019004203A2 (en) * 2016-09-02 2019-06-25 Univ Illinois construct, pharmaceutical composition, and methods for inhibiting angiogenesis and for treating a disease or disorder in an individual distinguished by excessive vascularization.
CA3075867A1 (en) * 2017-09-13 2019-03-21 Gene Techno Science Co., Ltd. Anti-ramp2 antibody
TWI847981B (en) * 2018-04-25 2024-07-11 比利時商健生藥品公司 Glucagon like peptide 1 (glp-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof
US10875902B2 (en) 2018-04-25 2020-12-29 Janssen Pharmaceutica Nv Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof
KR102116944B1 (en) * 2019-09-23 2020-05-29 주식회사 차메디텍 Novel peptide derivatives having melanin production inhibitory activity, pharmaceutically acceptable salts thereof, and composition for inhibiting melanin production comprising the same
CN117603364A (en) * 2022-09-30 2024-02-27 广西医科大学附属肿瘤医院 A class of GLP-1/glucagon/Y2 receptor triple agonists and their applications
CN119039381B (en) * 2024-10-29 2025-02-11 杭州佰倍优生物科技有限公司 Antibacterial pig spleen peptide and preparation method and application thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739106A (en) * 1995-06-07 1998-04-14 Rink; Timothy J. Appetite regulating compositions
AU718254B2 (en) * 1996-01-19 2000-04-13 Betagene, Inc. Recombinant expression of proteins from secretory cell lines
JP2000505105A (en) 1996-11-13 2000-04-25 ユニヴァーシティ・オブ・シンシナティ Analogs of peptide YY and uses thereof
EA004790B1 (en) * 1996-12-20 2004-08-26 Амген Инк. Ob fusion protein compositions and methods
US6506724B1 (en) * 1999-06-01 2003-01-14 Amylin Pharmaceuticals, Inc. Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
US6528486B1 (en) * 1999-07-12 2003-03-04 Zealand Pharma A/S Peptide agonists of GLP-1 activity
CA2396157A1 (en) * 2000-01-10 2001-07-19 Amylin Pharmaceuticals, Inc. Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia
BR0116024A (en) * 2000-12-07 2005-12-13 Lilly Co Eli Heterologous Fusion Protein and Use thereof
DE60228972D1 (en) * 2001-07-31 2008-10-30 Us Gov Health & Human Serv GLP 1 EXENDIN 4 PEPTIDE ANALOG AND THEIR USES
US7192922B2 (en) * 2002-11-19 2007-03-20 Allegheny-Singer Research Institute Method of treating left ventricular dysfunction
JP2006514035A (en) * 2002-12-17 2006-04-27 アミリン・ファーマシューティカルズ，インコーポレイテッド Prevention and treatment of cardiac arrhythmias
US7166575B2 (en) 2002-12-17 2007-01-23 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
US20070027073A1 (en) * 2003-04-08 2007-02-01 Menachem Rubinstein Long-acting derivatives of pyy agonists
EP2422806A3 (en) * 2004-02-11 2012-06-13 Amylin Pharmaceuticals Inc. Hybrid polypeptides with selectable properties

Also Published As

Publication number Publication date
ZA200801138B (en) 2008-12-31
KR20080045185A (en) 2008-05-22
JP2009504681A (en) 2009-02-05
EA014647B1 (en) 2010-12-30
KR101399178B1 (en) 2014-06-18
EA200800548A1 (en) 2008-08-29
MX2008002028A (en) 2008-03-27
CN101296942A (en) 2008-10-29

Similar Documents

Publication Publication Date Title
IL188937A0 (en) Hybrid polypeptides with selectable properties
IL177229A0 (en) Hybrid polypeptides with selectable properties
IL184428A0 (en) Peptides with neuropeptide-2-receptor
IL185563A0 (en) Gip analog and hybrid polypeptides with selectable properties
EP1928237A4 (en) Novel imidazo based heterocycles
GB0524788D0 (en) Polypeptides
ZA200810738B (en) Polypeptide
GB0721686D0 (en) Polypeptides
IL196960A0 (en) Anti-c5ar antibodies with improved properties
EP1868428A4 (en) Rubber-fiber hybrid
ZA200806320B (en) Diazepinones
EP1882128A4 (en) Electric range
GB2425585B (en) Mechanical override
GB0601471D0 (en) The cardioprotector
GB0712302D0 (en) Chrondroitinase polypeptides
GB0505949D0 (en) Polypeptides
GB0623539D0 (en) Polypeptides
IL231953A0 (en) Hybrid polypeptides with selectable properties
GB0521784D0 (en) Fuel system - 8
GB0602141D0 (en) The turboramjet
GB0504769D0 (en) Polypeptides
AU3315P (en) Zanlotriumph Lilium hybrid
AU3316P (en) Zanlortrofeo Lilium hybrid
AU3314P (en) Zanlorvenna Lilium hybrid
AU3195P (en) OHMADMADE Argyranthemum hybrid